Cargando…

Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review

BACKGROUND: Follicular dendritic cell sarcoma (FDCS) is an uncommon malignant cancer, and there is no standard treatment to date. Resection followed by adjuvant chemotherapy or radiation is considered the most commonly used strategy for treatment. However, the treatment for patients who have progres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Yanna, Zhao, Sha, Jiang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456086/ https://www.ncbi.nlm.nih.gov/pubmed/34566950 http://dx.doi.org/10.3389/fimmu.2021.653319

Ejemplares similares

Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report
por: Li, Jielang, et al.
Publicado: (2023)

Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antibody
por: Xu, Bin, et al.
Publicado: (2022)

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
por: Zhu, Chengpei, et al.
Publicado: (2023)

Mediastinal Follicular Dendritic Cell Sarcoma With Underlying Sjogren’s Syndrome
por: Phrathep, Davong D, et al.
Publicado: (2023)

Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study
por: Li, Shuqun, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study
por: Cai, Mingyue, et al.
Publicado: (2022)

High PD‐L1 level of advanced hepatic lymphoepithelioma‐like carcinoma response favorably to lenvatinib plus toripalimab
por: Zhu, Yueting, et al.
Publicado: (2022)

PD-1/L1 inhibitor plus chemotherapy in the treatment of sarcomas
por: Tian, Zhichao, et al.
Publicado: (2022)

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Follicular dendritic cell sarcoma
por: Facchetti, Fabio, et al.
Publicado: (2021)

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC
por: Wang, Yunchao, et al.
Publicado: (2023)

Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
por: Mei, Jie, et al.
Publicado: (2021)

Hepatic Tumor Stiffness Measured by Shear Wave Elastography Is Prognostic for HCC Progression Following Treatment With Anti-PD-1 Antibodies Plus Lenvatinib: A Retrospective Analysis of Two Independent Cohorts
por: Yuan, Guosheng, et al.
Publicado: (2022)

Multiple recurrent follicular dendritic cell sarcoma: A case report
por: Schorn, Lara, et al.
Publicado: (2020)

Unexpected Help: Follicular Regulatory T Cells in the Germinal Center
por: Xie, Markus M., et al.
Publicado: (2018)

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023)

Follicular dendritic cells in health and disease
por: El Shikh, Mohey Eldin M., et al.
Publicado: (2012)

Follicular Dendritic Cell Sarcoma of the Tonsil
por: Eun, Young Gyu, et al.
Publicado: (2010)

Follicular dendritic cell sarcoma of the tonsil
por: Mondal, Santosh Kumar, et al.
Publicado: (2012)

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inhibitors Plus Lenvatinib
por: Wang, Jinfeng, et al.
Publicado: (2023)

Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade
por: Ocadlikova, Darina, et al.
Publicado: (2021)

Small intestine follicular dendritic cell sarcoma with liver metastasis: A case report
por: Chang, Yun-Chen, et al.
Publicado: (2017)

Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients
por: Zou, Jixue, et al.
Publicado: (2022)

Follicular dendritic cell sarcoma of the pharyngeal region
por: HU, TENGPENG, et al.
Publicado: (2013)

Sorafenib, Lenvatinib, or Lenvatinib Combining PD-1 Inhibitors Plus TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Analysis
por: Zhao, Shu, et al.
Publicado: (2022)

Lenvatinib plus pembrolizumab in patients with advanced or recurrent uterine carcinosarcoma
por: Hunt, Jonathan T., et al.
Publicado: (2021)

CD301b(+) dendritic cells suppress T follicular helper cells and antibody responses to protein antigens
por: Kumamoto, Yosuke, et al.
Publicado: (2016)

The efficacy and safety of lenvatinib plus transarterial chemoembolization in combination with PD-1 antibody in treatment of unresectable recurrent hepatocellular carcinoma: a case series report
por: Mu, Chunyang, et al.
Publicado: (2023)

Determination of T Follicular Helper Cell Fate by Dendritic Cells
por: Krishnaswamy, Jayendra Kumar, et al.
Publicado: (2018)

Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma
por: Xie, Fucun, et al.
Publicado: (2022)

Host Factors of Favorable Intestinal Microbial Colonization
por: Pirr, Sabine, et al.
Publicado: (2020)

How Follicular Dendritic Cells Shape the B-Cell Antigenome
por: Kranich, Jan, et al.
Publicado: (2016)

Multidisciplinary diagnosis and treatment of recurrent follicular dendritic cell sarcoma in abdomen: A case report
por: Qu, Chang, et al.
Publicado: (2020)

Follicular Dendritic Cell Sarcoma of the Abdomen: the Imaging Findings
por: Kang, Tae Wook, et al.
Publicado: (2010)

Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
por: Shah, Pooja, et al.
Publicado: (2020)

A rare case of follicular dendritic sarcoma of the vagina
por: Gold, Joann M., et al.
Publicado: (2022)

Hepatic arterial infusion chemotherapy plus lenvatinib with or without programmed cell death protein-1 inhibitors for advanced cholangiocarcinoma
por: Wei, Zhanqi, et al.
Publicado: (2023)

Toll-Like Receptor Ligand Based Adjuvant, PorB, Increases Antigen Deposition on Germinal Center Follicular Dendritic Cells While Enhancing the Follicular Dendritic Cells Network
por: Lisk, Christina, et al.
Publicado: (2020)

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib
por: Xu, Yongkang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nrk48ch5oaaekkgrn9onqk718a